Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
mRNA expression of specific HER ligands and their association with clinical outcome in patients with metastatic breast cancer treated with trastuzumab.
Rapti V, Moirogiorgou E, Koliou GA, Papadopoulou K, Binas I, Pentheroudakis G, Bafaloukos D, Bobos M, Chatzopoulos K, Chrisafi S, Christodoulou C, Nicolaou I, Sotiropoulou M, Magkou C, Koutras A, Papakostas P, Kotsakis A, Razis E, Psyrri A, Tryfonopoulos D, Pectasides D, Res E, Alexopoulos A, Kotoula V, Fountzilas G. Rapti V, et al. Among authors: alexopoulos a. Oncol Lett. 2022 Jan;23(1):23. doi: 10.3892/ol.2021.13141. Epub 2021 Nov 17. Oncol Lett. 2022. PMID: 34868360 Free PMC article.
ABREAST: a prospective, real-world study on the effect of nab-paclitaxel treatment on clinical outcomes and quality of life of patients with metastatic breast cancer.
Koumarianou A, Makrantonakis P, Zagouri F, Papadimitriou C, Christopoulou A, Samantas E, Christodoulou C, Psyrri A, Bafaloukos D, Aravantinos G, Papakotoulas P, Baka S, Andreadis C, Alexopoulos A, Bompolaki I, Kampoli Κ, Liori S, Karvounis K, Ardavanis A. Koumarianou A, et al. Among authors: alexopoulos a. Breast Cancer Res Treat. 2020 Jul;182(1):85-96. doi: 10.1007/s10549-020-05677-4. Epub 2020 May 16. Breast Cancer Res Treat. 2020. PMID: 32418045
A Phase II trial of the combination of vinorelbine and capecitabine as second-line treatment in metastatic breast cancer previously treated with taxanes and/or anthracyclines.
Orphanos G, Alexopoulos A, Malliou S, Ioannidis G, Ardavanis A, Kandylis C, Stavrakakis J, Rigatos G. Orphanos G, et al. Among authors: alexopoulos a. J Cancer Res Clin Oncol. 2010 Jan;136(1):115-21. doi: 10.1007/s00432-009-0642-0. J Cancer Res Clin Oncol. 2010. PMID: 19672628 Clinical Trial.
Real-World Data on Health-Related Quality of Life Assessment in Patients With Breast Cancer Receiving Subcutaneous Trastuzumab.
Syrios J, Pappa E, Volakakis N, Grivas A, Alafis J, Manioudaki S, Tzouda V, Korogiannos A, Rapti C, Koufopoulos N, Nikolaidou A, Kanavou E, Alexopoulos A, Koumarianou A. Syrios J, et al. Among authors: alexopoulos a. Breast Cancer (Auckl). 2018 Feb 20;12:1178223418758031. doi: 10.1177/1178223418758031. eCollection 2018. Breast Cancer (Auckl). 2018. PMID: 29511355 Free PMC article.
Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.
Mavroudis D, Malamos N, Alexopoulos A, Kourousis C, Agelaki S, Sarra E, Potamianou A, Kosmas C, Rigatos G, Giannakakis T, Kalbakis K, Apostolaki F, Vlachonicolis J, Kakolyris S, Samonis G, Georgoulias V. Mavroudis D, et al. Among authors: alexopoulos a. Ann Oncol. 1999 Feb;10(2):211-5. doi: 10.1023/a:1008315723253. Ann Oncol. 1999. PMID: 10093691 Free article. Clinical Trial.
317 results